Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Long-Term Debt Repayments (2021 - 2025)

Definitive Healthcare (DH) has disclosed Long-Term Debt Repayments for 5 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments fell 36.34% year-over-year to $2.2 million, compared with a TTM value of $252.8 million through Dec 2025, up 1738.64%, and an annual FY2025 reading of $252.8 million, up 1738.64% over the prior year.
  • Long-Term Debt Repayments was $2.2 million for Q4 2025 at Definitive Healthcare, roughly flat from $2.2 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $470.4 million in Q3 2021 and bottomed at $1.2 million in Q1 2021.
  • Average Long-Term Debt Repayments over 5 years is $39.7 million, with a median of $2.2 million recorded in 2025.
  • The sharpest move saw Long-Term Debt Repayments crashed 99.63% in 2022, then skyrocketed 7062.59% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $470.4 million in 2021, then plummeted by 99.63% to $1.7 million in 2022, then skyrocketed by 100.0% to $3.4 million in 2023, then decreased by 0.03% to $3.4 million in 2024, then plummeted by 36.34% to $2.2 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for DH at $2.2 million in Q4 2025, $2.2 million in Q3 2025, and $2.2 million in Q2 2025.